Tower Research Capital LLC (Trc) Immatics N.V. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Immatics N.V. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,606 shares of IMTX stock, worth $19,472. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,606Holding current value
$19,472% of portfolio
0.0%Shares
13 transactions
Others Institutions Holding IMTX
# of Institutions
103Shares Held
75.9MCall Options Held
238KPut Options Held
727K-
Rtw Investments, LP New York, NY10MShares$54 Million1.82% of portfolio
-
Wellington Management Group LLP Boston, MA9.68MShares$52.3 Million0.02% of portfolio
-
Perceptive Advisors LLC New York, NY8.09MShares$43.7 Million2.41% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.38MShares$39.9 Million0.05% of portfolio
-
Baker Bros. Advisors LP New York, NY6.44MShares$34.8 Million0.79% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $412M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...